OIRA Conclusion of EO 12866 Regulatory Review
| RIN: 1210-AB32 View EO 12866 Meetings | Received Date: 01/28/2016 |
| Title: Conflict of Interest Rule--Investment Advice | |
| Agency/Subagency: DOL / EBSA | Stage: Final Rule |
| Concluded Action: Consistent with Change | Concluded Date: 04/03/2016 |
| Legal Deadline: None | Economically Significant: Yes |
| Publication Date: 04/08/2016 | Unfunded Mandates: Private Sector |
| Major: Yes | Related To Homeland Security: No |
| Regulatory Flexibility Analysis Required: Yes | Small Entities Affected: Businesses, Organizations |
| Federalism Implications: No | Affordable Care Act [Pub. L. 111-148 & 111-152]: No |
| International Impacts: No | Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]: No |
| Pandemic Response: Uncollected | |
An official website of the United States government



